logo
#

Latest news with #AMSC

AMSC Malaysia 2025 Set to Spotlight World-Class Expertise and Innovation in Aesthetic Medicine and Surgery
AMSC Malaysia 2025 Set to Spotlight World-Class Expertise and Innovation in Aesthetic Medicine and Surgery

Korea Herald

time5 days ago

  • Business
  • Korea Herald

AMSC Malaysia 2025 Set to Spotlight World-Class Expertise and Innovation in Aesthetic Medicine and Surgery

KUALA LUMPUR, Malaysia, July 24, 2025 /PRNewswire/ -- The Aesthetic Medicine & Surgery Conference & Exhibition (AMSC) returns for its fourth edition from August 6-7, 2025, with an expanded focus on global participation and advanced education. Held at the Kuala Lumpur Convention Centre (KLCC), AMSC 2025 will feature over 160 world-class speakers, 200 international brands, and 20 supporting partners, including 13 medical societies and 7 industry collaborators. More than 1,600 delegates from around the world are expected, with highlights including clinical innovation updates, live demonstrations, and expert insights from speakers representing over 30 countries. "AMSC Malaysia 2025 represents a global crossroads for aesthetic medicine, where regional insights meet international expertise. This year, we are not just sharing techniques, we are also building a collaborative future for the field by fostering dialogue, discovery, and innovation across borders," said Dr Tingsong Lim, President of the Malaysian Society of Aesthetic Medicine (MSAM) and Scientific Director of AMSC. Elevating Aesthetic and Regenerative Care for Diverse Needs AMSC Malaysia 2025 will explore a wide range of cutting-edge topics in aesthetic and regenerative medicine. These include Periorbital Rejuvenation, focusing on advanced techniques using fillers, threads, and devices to treat tear troughs and under-eye ageing; Melasma Management, with evidence-based protocols combining lasers, topicals, and regenerative treatments tailored for Asian skin; Facelift Techniques, covering both surgical and non-invasive approaches such as thread lifts, energy-based tightening, and facial sculpting; Longevity Medicine, exploring anti-ageing strategies that utilise semaglutide, hormones, peptides, and polydeoxyribonucleotides (PDRN); Regenerative Aesthetics, highlighting the use of exosomes, stem cells, and PRP to restore skin quality and stimulate collagen; Scar Treatment, featuring multi-modal solutions using lasers, injectables, and biostimulators for acne scars and post-surgical healing; and more. Through these sessions, delegates will gain in-depth knowledge of current clinical trends, master advanced injection and device-based techniques, and learn how to apply combination approaches for improved patient outcomes. The conference provides ample opportunities for attendees to explore innovations in regenerative medicine, deepen their understanding of tailored treatments for diverse skin types and enhance their ability to meet the growing demands of specialised patient segments, including male aesthetics and ageing populations. This year's AMSC welcomes a distinguished line-up of global experts who are redefining the standards of aesthetic and regenerative medicine: The PINOKIO Surgical Zone Returns with Expanded Hands-On Training Returning for its eighth edition in Malaysia, the PINOKIO Surgical Zone at AMSC 2025 brings back Korea's leading surgical organisation for an expanded three-day programme from 6 to 8 August 2025. In a groundbreaking collaboration, AMSC partners with the Plastic Innovative Nasal Ormaxillofacial Korean International Organisation (PINOKIO) to deliver an immersive and focused surgical education experience tailored for professionals seeking to refine their techniques and deepen their anatomical understanding. The agenda includes Day 1: Nose Surgery Focus, Day 2: Face and Chest Lift Techniques, and Day 3: Hands-on Cadaver Masterclass on Rhinoplasty and Surgical Facelift. Delegates will benefit from expert-led lectures, live cadaver dissections, and practical demonstrations guided by some of Asia's most respected surgeons. Additionally, the zone features a curated exhibition showcasing the latest tools and innovations in facial, nasal, and chest aesthetic surgery. Additionally, the exhibition hall will feature leading global brands such as Merz Aesthetics, Juvederm, Skinvive, Neauvia, Oligio, Gouri, Karisma, Multifrax, Sinclair, and Plinest, offering delegates hands-on access to the latest innovations in injectables, energy-based devices, and regenerative solutions.

The 4th Edition of AMSC Malaysia Returns in 2025: Uniting Global Leaders in Aesthetic Medicine, Dermatology, and Surgery
The 4th Edition of AMSC Malaysia Returns in 2025: Uniting Global Leaders in Aesthetic Medicine, Dermatology, and Surgery

Yahoo

time16-06-2025

  • Business
  • Yahoo

The 4th Edition of AMSC Malaysia Returns in 2025: Uniting Global Leaders in Aesthetic Medicine, Dermatology, and Surgery

KUALA LUMPUR, Malaysia, June 16, 2025 /PRNewswire/ -- The Aesthetic Medicine & Surgery Conference & Exhibition (AMSC) returns for its highly anticipated fourth edition on 6–7 August 2025 at the prestigious Kuala Lumpur Convention Centre (KLCC). Following the success of AMSC 2024, which welcomed over 1,500 participants and 153 expert speakers, the 2025 edition is set to raise the bar even higher. AMSC Malaysia 2025 will unite more than 1,600 delegates, 160 world-renowned speakers, 200 global brands, and 20 supporting partners, including 13 medical societies and 7 industry collaborators. The event strengthens its position as Southeast Asia's premier platform for innovation, education, and collaboration in aesthetic medicine, dermatology, and surgery. Two Days of Scientific Excellence and Global Networking Spanning two dynamic days, AMSC 2025 will showcase cutting-edge clinical advancements, live demonstrations, and cross-disciplinary knowledge sharing, featuring insights from over 160 speakers across 30 countries, including South Korea, Switzerland, and Australia. Topics will range from periorbital rejuvenation and facelift techniques to regenerative aesthetics, and skin tightening innovations. The exhibition hall will showcase more than 200 premium international brands, offering hands-on experiences with the latest products, devices, and technologies shaping the future of aesthetic medicine. Special Highlights at AMSC 2025 3rd Aesthetic Medicine Facial Anatomy Cadaver MasterclassA signature session for aesthetic professionals, this hybrid masterclass blends theoretical and practical approaches to facial anatomy. The session will feature distinguished aesthetic surgeons including Dr Konstantin Frank, a plastic surgeon from Spain, and Dr Luciano Lanfranchi, a renowned plastic surgeon from Italy, who will share expertise on anatomical safety and injectable treatment techniques. PINOKIO Surgical Zone Collaboration (6–8 August 2025)In a groundbreaking partnership, AMSC teams up with the Plastic Innovative Nasal Ormaxillofacial Korean International Organisation (PINOKIO) to deliver a three-day surgical education series: Day 1: Nose Surgery Focus Day 2: Face and Chest Lift Techniques Day 3: Hands-on Cadaver Masterclass – Rhinoplasty and Surgical Facelift This initiative provides immersive, skills-based training with guidance from Asia's most respected surgeons. SAM Conference by the Society of Aesthetic Medicine, SingaporeA new cross-border collaboration with Singapore's leading aesthetic medicine body, reinforcing regional cooperation and professional exchange between Malaysia and Singapore. Business Management Talk 2.0An enhanced forum delivering practical insights into clinic operations, branding, patient experience, and business strategy—equipping practitioners with tools for sustainable success. "AMSC Malaysia is more than just a conference – it's where the future of aesthetic medicine is shaped. Through scientific exchange, hands-on training, and meaningful connections, AMSC delivers a truly transformative experience," said Dr Ting Song Lim, President of Malaysia Society of Aesthetic Medicine (MSAM). Be part of Southeast Asia's most influential gathering of aesthetic physicians, dermatologists, and surgeons. For registration and further information, visit View original content to download multimedia: SOURCE Aesthetic Medicine & Surgery Conference & Exhibition Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Is American Superconductor (AMSC) Outperforming Other Computer and Technology Stocks This Year?
Is American Superconductor (AMSC) Outperforming Other Computer and Technology Stocks This Year?

Yahoo

time13-06-2025

  • Business
  • Yahoo

Is American Superconductor (AMSC) Outperforming Other Computer and Technology Stocks This Year?

The Computer and Technology group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has American Superconductor (AMSC) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Computer and Technology sector should help us answer this question. American Superconductor is one of 608 individual stocks in the Computer and Technology sector. Collectively, these companies sit at #7 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. American Superconductor is currently sporting a Zacks Rank of #2 (Buy). Within the past quarter, the Zacks Consensus Estimate for AMSC's full-year earnings has moved 2.5% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend. Our latest available data shows that AMSC has returned about 18.7% since the start of the calendar year. In comparison, Computer and Technology companies have returned an average of 2.5%. This shows that American Superconductor is outperforming its peers so far this year. Amphenol (APH) is another Computer and Technology stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 36.2%. For Amphenol, the consensus EPS estimate for the current year has increased 13.8% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy). Breaking things down more, American Superconductor is a member of the Electronics - Miscellaneous Components industry, which includes 26 individual companies and currently sits at #94 in the Zacks Industry Rank. On average, stocks in this group have gained 6.7% this year, meaning that AMSC is performing better in terms of year-to-date returns. In contrast, Amphenol falls under the Electronics - Connectors industry. Currently, this industry has 2 stocks and is ranked #4. Since the beginning of the year, the industry has moved +35.9%. Going forward, investors interested in Computer and Technology stocks should continue to pay close attention to American Superconductor and Amphenol as they could maintain their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American Superconductor Corporation (AMSC) : Free Stock Analysis Report Amphenol Corporation (APH) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Why American Superconductor (AMSC) Stock Is Down Today
Why American Superconductor (AMSC) Stock Is Down Today

Yahoo

time12-06-2025

  • Business
  • Yahoo

Why American Superconductor (AMSC) Stock Is Down Today

Shares of power resiliency solutions provider American Superconductor (NASDAQ:AMSC) fell 13.2% in the afternoon session after the company announced an underwritten public offering of 4.1 million shares of its common stock for $28 per share. AMSC expects the gross proceeds from this offering to be $115,500,000. Notably, before the announcement, AMSC had roughly 40m shares outstanding, which means the stock sale could significantly raise the supply. This could have a negative impact on its stock price as the increase in the supply of outstanding shares dilutes the ownership of existing shareholders. The shares closed the day at $29.65, down 13.8% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy American Superconductor? Access our full analysis report here, it's free. American Superconductor's shares are extremely volatile and have had 76 moves greater than 5% over the last year. But moves this big are rare even for American Superconductor and indicate this news significantly impacted the market's perception of the business. The previous big move we wrote about was 15 days ago when the stock gained 6% on the news that the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025. Companies with substantial business ties to Europe likely had some relief as the delay reduced near-term cost pressures and preserved cross-border demand. American Superconductor is up 17.3% since the beginning of the year, but at $29.97 per share, it is still trading 18.6% below its 52-week high of $36.81 from November 2024. Investors who bought $1,000 worth of American Superconductor's shares 5 years ago would now be looking at an investment worth $4,288. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Sign in to access your portfolio

American Superconductor (AMSC) Is a Great Choice for 'Trend' Investors, Here's Why
American Superconductor (AMSC) Is a Great Choice for 'Trend' Investors, Here's Why

Yahoo

time11-06-2025

  • Business
  • Yahoo

American Superconductor (AMSC) Is a Great Choice for 'Trend' Investors, Here's Why

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy. The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the stock alive. Our "Recent Price Strength" screen, which is created on a unique short-term trading strategy, could be pretty useful in this regard. This predefined screen makes it really easy to shortlist the stocks that have enough fundamental strength to maintain their recent uptrend. Also, the screen passes only the stocks that are trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness. (AMSC) is one of the several suitable candidates that passed through the screen. Here are the key reasons why it could be a profitable bet for "trend" investors. A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. AMSC is quite a good fit in this regard, gaining 80.9% over this period. However, it's not enough to look at the price change for around three months, as it doesn't reflect any trend reversal that might have happened in a shorter time frame. It's important for a potential winner to maintain the price trend. A price increase of 46.1% over the past four weeks ensures that the trend is still in place for the stock of this wind turbine component maker. Moreover, AMSC is currently trading at 85.2% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout. Looking at the fundamentals, the stock currently carries a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises -- the key factors that impact a stock's near-term price movements. The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Another factor that confirms the company's fundamental strength is its Average Broker Recommendation of #1 (Strong Buy). This indicates that the brokerage community is highly optimistic about the stock's near-term price performance. So, the price trend in AMSC may not reverse anytime soon. In addition to AMSC, there are several other stocks that currently pass through our "Recent Price Strength" screen. You may consider investing in them and start looking for the newest stocks that fit these criteria. This is not the only screen that could help you find your next winning stock pick. Based on your personal investing style, you may choose from over 45 Zacks Premium Screens that are strategically created to beat the market. However, keep in mind that the key to a successful stock-picking strategy is to ensure that it produced profitable results in the past. You could easily do that with the help of the Zacks Research Wizard. In addition to allowing you to backtest the effectiveness of your strategy, the program comes loaded with some of our most successful stock-picking strategies. Click here to sign up for a free trial to the Research Wizard today. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American Superconductor Corporation (AMSC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store